Amicogen succeeds in developing a ligand for next-generation antibody purification
2023-10-19 02:19:12 50-100% increase in antibody binding capacity, pH 4.0 elution efficiency, and NaOH stability compared to first-generation ligands. Widening the technology gap to accelerate entry into the global antibody purification resin market [바이오타임즈] Amicogen (CEO Park Cheol), which is leading the local production of essential biopharmaceutical component materials, announced on the 19th that it … Read more